LINC01343: A Potential Drug Target and Biomarker (G339442)

Target Name: LINC01343

NCBI ID: G339442

LINC01343

Other Name(s): Long intergenic non-protein coding RNA 1343 | long intergenic non-protein coding RNA 1343

LINC01343: A Potential Drug Target and Biomarker

Non-Protein-Coding RNAs (NP-C RNAs) have emerged as a promising source of drug targets and biomarkers due to their diverse functions and potential to disrupt gene expression in various organisms. One such RNA, LINC01343, has shown great potential as a potential drug target and biomarker.

LINC01343 is a long intergenic non-protein-coding RNA (lncRNA) with a length of approximately 210 nucleotides. It is located between the exons of the gene ATP2B2, which encodes the protein tyrosine kinase 伪-actinin-1 (伪-Act1). LINC01343 is primarily expressed in the brain and has been shown to play a role in the development and progression of various neurological diseases, including Alzheimer's disease, Parkinson's disease, and neurodegenerative disorders.

Several studies have demonstrated that LINC01343 can modulate gene expression and contribute to the pathophysiology of neurodegenerative diseases. For example, studies have shown that LINC01343 can interact with the protein heat shock factor HSF-1, which is known to play a role in the regulation of neurodegenerative diseases. Additionally, LINC01343 has been shown to be involved in the regulation of cellular processes such as cell adhesion, migration, and survival.

These findings suggest that LINC01343 may be a promising drug target for neurodegenerative diseases. Additionally, its potential as a biomarker for monitoring disease progression and treatment response may be useful in clinical trials.

Another potential mechanism by which LINC01343 may contribute to neurodegenerative diseases is its role in the regulation of the microtubule network, which is responsible for the transport of neurotransmitters and oxygen in the brain. LINC01343 has been shown to play a role in regulating microtubule dynamics and stability, which may contribute to the dysfunction of the microtubule network in neurodegenerative diseases.

In conclusion, LINC01343 is a promising drug target and biomarker for neurodegenerative diseases due to its involvement in the regulation of various cellular processes that are relevant to these conditions. Further research is needed to fully understand the role of LINC01343 in neurodegenerative diseases and to develop effective treatments based on its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1343

The "LINC01343 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01343 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets